Potential Antidiabetic Activity of Annona muricata Leaves as Enzyme α-amylase Inhibitor: In Silico Study

Authors

  • Zahra Putri Handirana Department of Medicinal Chemistry, Faculty of Pharmacy, Universitas Bakti Tunas Husada
  • Tresna Lestari Department of Medicinal Chemistry, Faculty of Pharmacy, Universitas Bakti Tunas Husada
  • Richa Mardianingrum Department of Pharmacy, Faculty of Health Science, Universitas Perjuangan
  • Ruswanto Ruswanto Department of Medicinal Chemistry, Faculty of Pharmacy, Universitas Bakti Tunas Husada

DOI:

https://doi.org/10.15408/jkv.v12i1.46091

Keywords:

Acarbose, Annona muricata, antidiabetic, α-amylase

Abstract

Diabetes mellitus is a prevalent metabolic disorder requiring effective and safe therapeutic approaches. Natural compounds have gained attention as potential alternatives to synthetic drugs such as acarbose, which may cause adverse effects. This study aimed to evaluate the antidiabetic potential of secondary metabolites from Annona muricata leaves as α-amylase inhibitors using an in-silico approach. Molecular docking (PyRx), molecular dynamics simulation (Desmond, 100 ns), and ADMET prediction were performed to assess binding affinity, stability, and drug-likeness properties. Among the tested compounds, three lead compounds exhibited the strongest binding affinity: coclaurine (-9.25 kcal/mol), (+)(-) Xylopine (-8.94 kcal/mol), and annomuricine (-8.82 kcal/mol) compared to acarbose (-4.95 kcal/mol). Molecular dynamics analysis demonstrated annomuricine was the most stable interaction with key catalytic residues (Asp197, Glu233, and Asp300). Additionally,annomuricine satisfied Lipinski’s Rule of Five and showed favorable pharmacokinetic profiles, although it interacted with CYP enzymes. In conclusion, annomuricine demonstrates strong potential as a natural α-amylase inhibitor and may serve as a promising candidate for antidiabetic drug development. However, further in vitro and in vivo studies are required to validate these findings.

Downloads

Download data is not yet available.

References

1. World Health Organization. Diabetes. Published 2023. Accessed April 16, 2024. https://www.who.int/health-topics/diabetes#tab=tab_1

2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. (Boyko EJ, Magliano DJ, Karuranga S, Piemonte L, Saeedi PRP, Sun H, eds.); 2021.

3. Sani FN, Widiastuti A, Ulkhasanah ME, Amin NA. Overview of Quality of Life in Diabetes Mellitus Patients. J Nurse Research Prof. 2023;5(3):1151-1158. https://ejournal.helvetia.ac.id/jdg%0Ahttp://jurnal.globalhealthsciencegroup.com/index.php/JPPP

4. Budianto RE, Linawati NM, Arijana IGKN, Wahyuniari IAI, Wiryawan IGNS. Potential of Phytochemical Compounds in Plants in Lowering Blood Glucose Levels in Diabetes Mellitus. J Science and Health. 2022;4(5):548-556. doi:10.25026/jsk.v4i5.1259

5. Perkeni. Guidelines for the Management and Prevention of Type 2 Diabetes Mellitus in Indonesia 2021. PB Perkeni; 2021.

6. Alqahtani AS, Hidayathulla S, Rehman T, Elgamal AA, Dib RA El, Alajmi MF. Α-amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from Nuxia oppositifolia. Biomolecules. Published online 2019. doi:doi:10.3390/biom10010061

7. Sy SD, Nst MR, Jannah NR. Analysis of Infusion and Ethanol Extract of Tamarindus indica L, Scurrula Sp, Mimosa pudica D of Fresh and Dry as Amylase Enzyme Inhibitor. 2019;17(2):25-31.

8. Mahfur, Walid M. Antidiabetic combination test between durian leather extract and acarbose by combination index control of antidiabetic enzym α-amylase. Pharm J Indones. 2019;16(01):85-95.

9. Melinda NA, Kusumo DW, Indah D, Sari K. Antidiabetes activity of some fractions of Azadirachta indica leaves in vitro based on inhibition of α-amylase enzymes. 2023;27(3):82-87. doi:10.20956/mff.v27i3.28301

10. Mutakin, Fauziati R, Fadhilah FN, Zuhrotun A, Amalia R, Hadisaputri YE. Pharmacological Activities of Soursop (Annona muricata Lin.). Published online 2022:1-17. doi:https://doi.org/10.3390/molecules27041201

11. Lienggonegoro LA. Soursop leaf (Annona muricata) and its potential as an anti-cancer. 2022;(May). doi:10.13057/psnmbi/m060128

12. Rasyidah, Hutasuhut MA. Etnobotany study and pharmacological activity of Annona muricata L. leaves extract. Chlorophyll. 2019;3(2):10-14.

13. Agu KC, Eluehike N, Ofeimun RO, et al. Possible anti-diabetic potentials of Annona muricata (soursop): inhibition of α-amylase and α-glucosidase activities. Clin Phytoscience. Published online 2019. doi:https://doi.org/10.1186/s40816-019-0116-0

14. Kusuma GPOR. Antihyperglycemic Test of Ethanol Extract of Soursop Leaf (Annona muricata L.) on Blood Sugar Levels of Glucose-Induced Male Mice (Mus musculus) Antihyperglycemic Test of Ethanol Extract of Soursop Leaf (Annona muricata L.) on Blood Sugar Levels of Mal. J Natur Indonesia. 2021;19(1):1-5.

15. Opara PO, Enemor VHA, Eneh FU, Emengaha FC. Blood Glucose - Lowering Potentials of Annona muricata Leaf Extract in Alloxan - Induced Diabetic Rats. Eur J Biol Biotechnol. 2021;2(2):106-113.

16. Ogunyemi OM, Gyebi GA, Saheed A, et al. Inhibition mechanism of alpha-amylase, a diabetic target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth. Frontiers (Boulder). 2022;(August):1-19. doi:10.3389/fmolb.2022.866719

17. Ischak NI, Musa WJA, Aman LO, Alio L, Kilo A La, Saleh SD. Molecular Docking Study and ADME Prediction of Secondary Metabolite Compounds of Gorontalo Traditional Medicinal Plants against HER-2 Receptor as Breast Anticancer. 2023;5(1):90-103.

18. Renadi S, Tri A, Pratita K, Mardianingrum R. The Potency of Alkaloid Derivates as Anti-Breast Cancer Candidates: In Silico Study. 2023;9(May):89-108. doi:10.15408/jkv.v9i1.31481

19. Hanif AU, Lukis PA, Fadlan A. Effect of MMFF94 Energy Minimization with MarvinSketch and Open Babel PyRx on. Alchemy J Chem. Published online 2021.

20. Ruswanto R, No T, Mardianingrum R, Kesuma D. Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment. Heliyon. 2022;8(April). doi:10.1016/j.heliyon.2022.e10694

21. Umar AB, Uzairu A, Uba S, Shallangwa GA. In silico Studies of some potential anti-cancer agents on M19-MEL cell line. Moroccan J Chem. 2021;9(2):260-273.

22. Pan A, Pranavathiyani G, Chakraborty S Sen. Chapter 8 - Computational Modeling of Protein Three-Dimensional Structure: Methods and Resources. In: Coumar MSBTMD for CADD, ed. Academic Press; 2021:155-178. doi:https://doi.org/10.1016/B978-0-12-822312-3.00023-0

23. Noer S, Khairullah MF. In-Silico Study of Luteolin Compound as Breast Anticancer Drug Candidate. Semin Nas Sains. 2023;1(1):16-22. https://prediction.charite.de/

24. Komari N, Hadi S, Suhartono E. Protein modeling with Homology Modeling using SWISS-MODEL. J Network Mat and Science. 2020;2(2):65-70. doi:10.36873/jjms.2020.v2.i2.408

25. Sumitha A, Devi PB, Hari S, Dhanasekaran R. COVID-19 - In Silico Structure Prediction and Molecular Docking Studies with Doxycycline and Quinine. Biomed Pharmacol J. 2020;13(3):1185-1193. doi:10.13005/bpj/1986

26. Gaffar S, Masyhuri AA, Hartati YW, Rustaman R. Studi in Silico Single Chain Variable Fragment (Scfv) Selektif Terhadap Hormon Basic Natriuretic Peptide (Bnp). Chimica et Natura Acta. 2016 Aug 12;4(2):52-9.

27. Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of Polypeptide Chain Configurations. J Mol Biol. 1963;7(1):95-99. doi:10.1016/S0022-2836(63)80023-6

28. Ghandadi M. An Immunoinformatic Strategy to Develop New Mycobacterium tuberculosis Multi - epitope Vaccine. Int J Pept Res Ther. 2022;28(3):1-14. doi:10.1007/s10989-022-10406-0

29. Oladejo DO, Oduselu GO, Dokunmu TM, et al. In silico Structure Prediction, Molecular Docking, and Dynamic Simulation of Plasmodium falciparum AP2-I Transcription Factor. J Genet Eng Biotechnol. 2023;21(44). doi:10.1177/11779322221149616

30. Rastini MBO, Giantari NKM, Andyani KD, Udayana NPL. Molecular Docking Anticancer Activity of Quercetin Against Breast Cancer In Silico. Published online 2019. doi:https://doi.org/10.24843/JCHEM.2019.v13.i02.p09

31. Nuraini M, Ruswanto R. In Silico Study of Galangin Compound of Galangal (Alpinia galanga) as Anticancer against Breast Cancer. Published online 2021.

32. Nugroho AW, Fauzi A. Molecular docking study of acetoxychavicol acetate (ACA) flower solutions on target proteins ER-α, ER-β, and HER-2 as cytotoxic agents. Pharmaceutics. 2024;13(3):111-122.

33. Naufa F, Mutiah R, Yen Yen IA. In Silico Study of Potential of Green Tea Catechin Compounds (Camellia sinensis) as SARS CoV-2 Antivirus against Spike Glycoprotein (6LZG) and Main Protease (5R7Y). J food Pharm Sci. 2022;10(1):584-596.

34. Sari IW, Junaidin, Pratiwi D. Molecular Docking Study of Flavonoid Compound of Herba Kumis Kucing (Orthisiphon stamineus B.) on Alpha-Glucosidase Receptor as Antidiabetes Type 2. J Farmagazine. 2020;7(2):54-60.

35. Nursamsiar N, Awaluddin A, Nur S. In Silico Study of Aglycon Curculigoside A and Its Derivatives as α -Amilase In Silico Study of Aglycon Curculigoside A and Its Derivatives as α -Amilase Inhibitors In Silico Study of Aglycon Curculigoside A and Its Derivatives as α -Amilase Inhibitors. 2020;(December). doi:10.24198/ijpst.v7i1.23062

36. Afliana D, Ariyanti D. Molecular Docking Analysis of Secondary Metabolite Compounds from Trichoderma sp. isolates. Against Cutinase Enzyme Receptor in Fusarium Wilt Disease. J Life Sci Technol. 2024;2(2):25-39.

37. Ekawasti F, Sa'diah S, Cahyaningsih U, Dharmayanti NLPI, Subekti DT. Molecular Docking of Red Ginger and Turmeric Compounds on Dense Granules Protein - 1 Toxoplasma gondii with In Silico Method. J Vet. 2021;22(36):474-484. doi:10.19087/jveteriner.2021.22.4.474

38. Faqiha AF, Indrawijaya YYA, Suryadinata A, Amiruddin M, Mutiah R. Potential of Nitazoxanide and Arbidol Compounds as SARS-CoV-2 Antivirus against NSP5 (7BQY and 2GZ7) and ACE2 (3D0G and 1R4L) Receptors. 2022;5(March 2024). doi:10.22146/jfps.3393

39. Sharma A, Ahmed SSSJ. Network-Derived Radioresistant Breast Cancer Target with Candidate Inhibitors from Brown Algae: A Sequential Assessment from Target Selection to Quantum Chemical Calculation. Mar Drugs. 2023;21(10).

40. Fischer ALM, Tichy A, Kokot J, et al. The Role of Force Fields and Water Models in Protein Folding and Unfolding Dynamics. J Chem Theory Comput. 2024;20(5):2321-2333. doi:10.1021/acs.jctc.3c01106

41. Prasetiawati R, Damayanti A, Suwandi DW. Molecular Dynamics Simulation of Active Compounds of Tangkur Fern Root (Polypodium feei METT) as an Inhibitor of Inducible Nitric Oxide Synthase (iNOS) Enzyme. In: Proceedings of the National Seminar on Research Dissemination. Vol 3. ; 2023:390-400.

42. Zubair MS, Maulana S, Mukaddas A. Molecular Inhibition and Molecular Dynamics Simulation of Compounds from the Nigella Genus on the Inhibition of HIV-1 Protease Enzyme Inhibitors Activity.) J Farm Galen. 2020;6(1):132-140. doi:10.22487/j24428744.2020.v6.i1.14982

43. Sari BL, Suhendar U, Hamdani R. Implementation and simulation of molecular dynamics of bioactive compounds of Eleutherine sp. as a hepatitis B virus capsid inhibitor. Farmamedika. 2023;8(2):103-110.

44. Abdalla M, Ali W, El-arabey AA, Singh K, Jiang X. Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties. Comput Biol Med. 2021; (November).

45. Gholam GM. Molecular docking of the bioactive compound Ocimum sanctum as an inhibitor of Sap 1 Candida albicans. Sasambo J Pharm. 2022;3(1).

46. Moazzam M, Rasheed B, Sarfraz MT, Rana MM, Taj MH. Molecular Interaction Of Acetyl-Coa Carboxylase (Accase) With Fenoxaprop-P Ethyl Through Computational Analysis. J Pharm Negat Results. 2023;14(4):554-559. doi:10.47750/pnr.2023.14.04.67

47. Sherlin A, Mathew A, Lakshmipriya M. Understanding the Activating Mechanism of the Immune System against COVID-19 by Traditional Indian Medicine: Network Pharmacology Approach. Vol 129. 1st ed. Elsevier Inc; 2022. doi:10.1016/bs.apcsb.2021.11.007

48. Angelina M, Koban G, Lestari SR, Setiowati FK. In Silico Analysis of Naringenin from Stone Root Tubers (Gerrardanthus macrorhizus Harv. ex Benth. & Hook. f.) as Antitussive against N-methyl-D-aspartate Receptor. J of Life Sciences. 2022;7(3):172-182. doi:10.24002/biota.v7i3.5912

49. Weni M, Safithri M, Seno DSH. Molecular Docking of Active Compounds Piper crocatum on The Alpha- Glucosidase Enzyme as Antidiabetic Molecular Docking of Active Compounds Red Betel Leaf (Piper Crocatum) on the Αlfa-Glucosidase Enzyme as Antidiabetic. Indones J Pharm Sci Technol. 2020;7(2):64-72.

50. Karim BK, Tsamarah DF, Zahira A, et al. In-Silico Study of Active Compounds in Guava Leaves (Psidium guajava L.) as Candidates for Breast Anticancer Drugs In-Silico Study of Active Compounds in Guava Leaves (Psidium guajava L.) as. Indones J Biol Pharm. 2024;3(3):194-209.

51. Wulandari RP, Gabriel K, Nurdin HA, et al. Indonesian Journal of In Silico Study of Secondary Metabolite Compounds in Parsley (Petroselinum crispum) as a Drug Therapy for Blood Cancer (Myeloproliferative Neoplasm (MPN)) targeting JAK-2. Chem Sci. 2023;12(2).

52. Herdini, Setyawati IR. In Silico Study: Active Compounds of Senggugu Root (Clerodendrum serratum) against Human Chitotriosidase-1 (hCHIT1) Receptor Inhibition as Asthma. SCIENCESTECH. 2023;33(2):91-107.

53. Ruswanto R, Mardianingrum R, Yanuar A. Computational Studies of Thiourea Derivatives as Anticancer Candidates through Inhibition of Sirtuin-1 (SIRT1). J Kim Sains dan Apl Vol 25, No 3 Vol 25 Issue 3 Year 2022. Published online 2022. doi:10.14710/jksa.25.3.87-96

54. Nursanti O. Toxicity prediction and pharmacokinetics to get antidiabetes medicine identification. J Pharm Care Sci. 2023;3(2):1-9.

55. Du B xue, Xu Y, Yiu SM, Yu H, Sh JY. ADMET property prediction via multi-task graph learning under adaptive auxiliary task selection. iScience. 2023;26. doi:10.1016/j.isci.2023.108285

56. Klimoszek D, Jele M, Dołowy M. Study of the Lipophilicity and ADMET Parameters of New Anticancer Diquinothiazines with Pharmacophore Substituents. Pharmaceuticals. 2024;17(6).

57. Effendi N, Saputri NA, Purnomo H, Aminah. In Silico ADME-T and Molecular Docking of Tamoxifen Analogs as Breast Cancer Therapy Agent Candidates. Media Farm. 2023;19(1). doi: 10.32382/mf.v19i1.3305

Downloads

Published

2026-06-06

Issue

Section

Jurnal Kimia VALENSI, Volume 12, No. 1, May 2026

How to Cite

Potential Antidiabetic Activity of Annona muricata Leaves as Enzyme α-amylase Inhibitor: In Silico Study. (2026). Jurnal Kimia Valensi, 12(1), 132-143. https://doi.org/10.15408/jkv.v12i1.46091